Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Sees Unusually-High Trading Volume – What’s Next?

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) saw strong trading volume on Tuesday . 311,679 shares traded hands during mid-day trading, an increase of 251% from the previous session’s volume of 88,883 shares.The stock last traded at $9.94 and had previously closed at $10.02.

Shionogi & Co., Ltd. Unsponsored ADR Trading Up 0.6%

The business has a 50-day moving average of $8.89 and a 200-day moving average of $8.68. The stock has a market capitalization of $17.15 billion, a price-to-earnings ratio of 15.75, a PEG ratio of 2.07 and a beta of 0.19. The company has a debt-to-equity ratio of 0.01, a quick ratio of 5.74 and a current ratio of 6.44.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) last issued its quarterly earnings data on Monday, October 27th. The company reported $0.18 earnings per share for the quarter, beating analysts’ consensus estimates of $0.16 by $0.02. The company had revenue of $740.85 million during the quarter, compared to analysts’ expectations of $742.35 million. Shionogi & Co., Ltd. Unsponsored ADR had a return on equity of 11.90% and a net margin of 39.53%. As a group, research analysts forecast that Shionogi & Co., Ltd. Unsponsored ADR will post 0.66 EPS for the current year.

Shionogi & Co., Ltd. Unsponsored ADR Company Profile

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company’s product portfolio spans both established and innovative therapies.